Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/3/2024 | $8.00 → $6.00 | Sector Outperform → Sector Perform | Scotiabank |
| 11/13/2023 | $9.00 | Sector Perform → Sector Outperform | Scotiabank |
| 9/29/2023 | $9.00 | Sector Perform | Scotiabank |
| 6/27/2023 | $6.50 | Neutral | B. Riley Securities |
| 5/12/2023 | $5.00 → $7.50 | Sell → Hold | Tudor, Pickering, Holt & Co. |
| 4/13/2023 | $9.00 → $7.00 | Sell → Neutral | UBS |
| 12/14/2022 | $9.00 | Sell | UBS |
Clear Street's Newest Offering, with In-Depth Market Analysis and Investment Insights, Addresses the Firm's Rapidly Expanding Institutional Client Base Initial Sector Coverage Includes Disruptive Technology, Energy Transition and Healthcare Clear Street ("Clear Street", "the Company"), a cloud-native financial technology firm on a mission to modernize the brokerage ecosystem, today announced the launch of its Equity Research Group, a strategic initiative aimed at providing in-depth market analysis and investment insights to its growing institutional client base. Led by Director of Research Mara Goldstein, Clear Street Equity Research will focus initially on the Disruptive Technology, En
PITTSBURGH, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Montauk Renewables, Inc. ("Montauk" or "the Company") (NASDAQ:MNTK), a renewable energy company specializing in the management, recovery, and conversion of biogas into renewable natural gas ("RNG"), today announced financial results for the third quarter ended September 30, 2024. Third Quarter Financial Highlights: RINs Sold of 15.8 million, increased 14.5% compared to the third quarter of 2023 Revenues of $65.9 million, increased 18.4% compared to the third quarter of 2023 Net Income of $17.0 million, increased 31.8% compared to the third quarter of 2023 Non-GAAP Adjusted EBITDA of $29.4 million, increased 31
The company has secured partnerships with major biogas suppliers, green methanol product offtakers, equipment and technology corporations, and a licensing agreement with MIT. Emvolon, an MIT spun-off technology company that converts greenhouse gas emissions into carbon-negative fuels and chemicals, today announced several commercial and technical milestones. Following its recent field pilot announcement with Montauk Renewables to demonstrate the benefits of converting biogas into green methanol, Emvolon has secured multiple new partnerships with biogas suppliers, green methanol product offtakers, and multinational equipment and technology companies. Additionally, Emvolon announced that MIT
Montauk Renewables (NASDAQ:MNTK) reported quarterly earnings of $0.01 per share which met the analyst consensus estimate. This is a 133.33 percent increase over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $38.787 million which missed the analyst consensus estimate of $44.921 million by 13.66 percent. This is a 102.50 percent increase over sales of $19.154 million the same period last year.
B. Riley Securities analyst Ryan Pfingst maintains Montauk Renewables (NASDAQ:MNTK) with a Neutral and lowers the price target from $7 to $6.
Scotiabank downgraded Montauk Renewables from Sector Outperform to Sector Perform and set a new price target of $6.00 from $8.00 previously
Scotiabank upgraded Montauk Renewables from Sector Perform to Sector Outperform and set a new price target of $9.00
Scotiabank initiated coverage of Montauk Renewables with a rating of Sector Perform and set a new price target of $9.00
10-Q - Montauk Renewables, Inc. (0001826600) (Filer)
8-K - Montauk Renewables, Inc. (0001826600) (Filer)
8-K - Montauk Renewables, Inc. (0001826600) (Filer)
SC 13G - Montauk Renewables, Inc. (0001826600) (Subject)
SC 13G - Montauk Renewables, Inc. (0001826600) (Subject)
SC 13G/A - Montauk Renewables, Inc. (0001826600) (Subject)
PITTSBURGH, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Montauk Renewables, Inc. ("Montauk" or "the Company") (NASDAQ:MNTK), a renewable energy company specializing in the management, recovery, and conversion of biogas into renewable natural gas ("RNG"), today announced financial results for the third quarter ended September 30, 2024. Third Quarter Financial Highlights: RINs Sold of 15.8 million, increased 14.5% compared to the third quarter of 2023 Revenues of $65.9 million, increased 18.4% compared to the third quarter of 2023 Net Income of $17.0 million, increased 31.8% compared to the third quarter of 2023 Non-GAAP Adjusted EBITDA of $29.4 million, increased 31
PITTSBURGH, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Montauk Renewables, Inc. ("Montauk" or "the Company") (NASDAQ:MNTK), a renewable energy company specializing in the management, recovery and conversion of biogas into renewable natural gas ("RNG"), will host a conference call and webcast on Tuesday, November 12, 2024, at 5:00 p.m. Eastern time to discuss its financial results for the third quarter ended September 30, 2024. The Company will issue a press release reporting the financial results after the close of regular stock market trading hours on the same day as the conference call and webcast. Third Quarter 2024 Conference Call and Webcast Details Date: Tuesday, November 12, 2024Time: 5:0
PITTSBURGH, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Montauk Renewables, Inc. ("Montauk" or "the Company") (NASDAQ:MNTK), a renewable energy company specializing in the management, recovery, and conversion of biogas into renewable natural gas ("RNG"), today announced financial results for the second quarter ended June 30, 2024. Second Quarter Financial Highlights: Unsold RINs of 4.7 million as of June 30, 2024, increased 58.7% compared to the second quarter of 2023 In July 2024, committed for transfer all 4.7 million unsold RINs as of June 30, 2024 at average price of $3.32 compared to second quarter of 2024 average index price of $3.20 Revenues of $43.3 million, decreased 18.6% compa
3 - Montauk Renewables, Inc. (0001826600) (Issuer)
4 - Montauk Renewables, Inc. (0001826600) (Issuer)
4 - Montauk Renewables, Inc. (0001826600) (Issuer)